Manipulation of hydrogel assembly and growth factor delivery via the use of peptide-polysaccharide interactions.

The design of materials in which assembly, mechanical response, and biological properties are controlled by protein-polysaccharide interactions could provide materials that mimic the biological environment and find use in the delivery of growth factors. In the investigations reported here, a heparin-binding, coiled-coil peptide, PF4 ZIP, was employed to mediate the assembly of heparinized polymers. The heparin-binding affinity of this peptide was compared with that of other heparin-binding peptides (HBP) via heparin-sepharose chromatography and surface plasmon resonance (SPR) experiments. Results from these experiments indicate that PF4 ZIP demonstrates a higher heparin-binding affinity and heparin association rate when compared to the heparin-binding domains of antithrombin III (ATIII) and heparin-interacting protein (HIP). Viscoelastic hydrogels were formed upon the association of PF4 ZIP-functionalized star poly(ethylene glycol) (PEG-PF4 ZIP) with low-molecular-weight heparin-functionalized star PEG (PEG-LMWH). The viscoelastic properties of the hydrogels can be altered via variations in the ratio of LMWH to PF4 ZIP. bFGF release from these gels have also been investigated. Comparison of the bFGF release profiles with the hydrogel erosion profiles indicates that bFGF delivery from this class of hydrogels is mainly an erosion-controlled process and the rates of bFGF release can be modulated via choice of HBP or via variations in the mechanical properties of the hydrogels. Manipulation of hydrogel physical properties and erosion profiles will provide novel materials for controlled growth factor delivery and other biomedical applications.

[1]  Robert Langer,et al.  Advancing the field of drug delivery: taking aim at cancer. , 2003, Cancer cell.

[2]  J. Hubbell,et al.  Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Kristi L Kiick,et al.  Functionalizing electrospun fibers with biologically relevant macromolecules. , 2005, Biomacromolecules.

[4]  R. Linhardt,et al.  Heparin-protein interactions. , 2002, Angewandte Chemie.

[5]  W. Kett,et al.  Heparan sulfate-protein interactions: therapeutic potential through structure-function insights , 2005, Cellular and Molecular Life Sciences CMLS.

[6]  Takashi Miyata,et al.  A reversibly antigen-responsive hydrogel , 1999, Nature.

[7]  Glenn D Prestwich,et al.  Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. , 2005, Biomaterials.

[8]  R. Heinrikson,et al.  Amino acid sequence of human platelet factor 4. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Jeffrey D. Esko,et al.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.

[10]  Wim E. Hennink,et al.  Novel crosslinking methods to design hydrogels , 2002 .

[11]  Ziwei Huang,et al.  A natural motif approach to protein design: a synthetic leucine zipper peptide mimics the biological function of the platelet factor 4 protein , 1997, FEBS letters.

[12]  G. L. Bretthorst,et al.  Thermodynamics and kinetics of a folded-folded' transition at valine-9 of a GCN4-like leucine zipper. , 1999, Biophysical journal.

[13]  A. Panitch,et al.  Physical polymer matrices based on affinity interactions between peptides and polysaccharides. , 2003, Biomacromolecules.

[14]  Mustapha Mabrouki,et al.  PEG-Based Hydrogel Synthesis via the Photodimerization of Anthracene Groups , 2002 .

[15]  Wayne A. Hendrickson,et al.  Structure of a heparin-linked biologically active dimer of fibroblast growth factor , 1998, Nature.

[16]  V. Breedveld,et al.  Reversible hydrogels from self-assembling genetically engineered protein block copolymers. , 2005, Biomacromolecules.

[17]  P. Pudney,et al.  Novel Amyloid Fibrillar Networks Derived from a Globular Protein: β-Lactoglobulin† , 2002 .

[18]  A A Poot,et al.  Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[19]  M. Mack,et al.  Interference with Heparin Binding and Oligomerization Creates a Novel Anti-Inflammatory Strategy Targeting the Chemokine System , 2004, The Journal of Immunology.

[20]  A. Kentsis,et al.  Transition state heterogeneity in GCN4 coiled coil folding studied by using multisite mutations and crosslinking. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Sasisekharan,et al.  Heparin and heparan sulfate: biosynthesis, structure and function. , 2000, Current opinion in chemical biology.

[22]  L. Chen,et al.  Crystal structure of recombinant human platelet factor 4. , 1994, Biochemistry.

[23]  J. Mcdonald,et al.  Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[24]  Robert Langer,et al.  Advances in Biomaterials, Drug Delivery, and Bionanotechnology , 2003 .

[25]  Tobin R. Sosnick,et al.  The role of helix formation in the folding of a fully α‐helical coiled coil , 1996 .

[26]  C. Matthews,et al.  Probing the folding mechanism of a leucine zipper peptide by stopped-flow circular dichroism spectroscopy. , 1995, Biochemistry.

[27]  J. Weiler,et al.  Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides. , 1997, Archives of biochemistry and biophysics.

[28]  Salt-bridges can stabilize but do not accelerate the folding of the homodimeric coiled-coil peptide GCN4-p1. , 2004, Journal of molecular biology.

[29]  Alyssa Panitch,et al.  Polymeric biomaterials for tissue and organ regeneration , 2001 .

[30]  Russell J. Stewart,et al.  Hybrid hydrogels assembled from synthetic polymers and coiled-coil protein domains , 1999, Nature.

[31]  G. L. Bretthorst,et al.  Temperature dependence of the folding and unfolding kinetics of the GCN4 leucine zipper via 13C(alpha)-NMR. , 2001, Biophysical journal.

[32]  C. Matthews,et al.  A buried polar residue in the hydrophobic interface of the coiled-coil peptide, GCN4-p1, plays a thermodynamic, not a kinetic role in folding. , 2002, Journal of molecular biology.

[33]  Ralph Müller,et al.  Repair of bone defects using synthetic mimetics of collagenous extracellular matrices , 2003, Nature Biotechnology.

[34]  C. Matthews,et al.  Preformed secondary structure drives the association reaction of GCN4-p1, a model coiled-coil system. , 2000, Journal of molecular biology.

[35]  Yasuo Suzuki,et al.  Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release. , 2003, Journal of biomedical materials research. Part A.

[36]  J. Hubbell,et al.  Development of fibrin derivatives for controlled release of heparin-binding growth factors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Matthias P Lutolf,et al.  Biopolymeric delivery matrices for angiogenic growth factors. , 2003, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[38]  D. Rifkin,et al.  Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. , 1994, The Journal of biological chemistry.

[39]  A. Albertsson,et al.  Biodegradable polymers from renewable sources: rheological characterization of hemicellulose-based hydrogels. , 2005, Biomacromolecules.

[40]  Laura A. Poole-Warren,et al.  A photo-crosslinked poly(vinyl alcohol) hydrogel growth factor release vehicle for wound healing applications , 2003, AAPS PharmSci.

[41]  J. Hubbell,et al.  Materials for Cell Encapsulation via a New Tandem Approach Combining Reverse Thermal Gelation and Covalent Crosslinking. , 2002 .

[42]  A. Pandit,et al.  Enzymatic stabilization of gelatin-based scaffolds. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.

[43]  V. Conticello,et al.  Self-assembly of block copolymers derived from elastin-mimetic polypeptide sequences. , 2002, Advanced drug delivery reviews.

[44]  Mari Dezawa,et al.  Novel heparin/alginate gel combined with basic fibroblast growth factor promotes nerve regeneration in rat sciatic nerve. , 2004, Journal of biomedical materials research. Part A.

[45]  Kristi L Kiick,et al.  Rheological characterization of polysaccharide-poly(ethylene glycol) star copolymer hydrogels. , 2005, Biomacromolecules.

[46]  Byung-Soo Kim,et al.  Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[47]  S. Craig,et al.  Rational Control of Viscoelastic Properties in Multicomponent Associative Polymer Networks , 2005 .

[48]  D Seliktar,et al.  MMP-2 sensitive, VEGF-bearing bioactive hydrogels for promotion of vascular healing. , 2004, Journal of biomedical materials research. Part A.

[49]  Lauren Flynn,et al.  Manufacture of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) hydrogel tubes for use as nerve guidance channels. , 2002, Biomaterials.

[50]  S. Zalipsky.  Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates. , 1995, Bioconjugate chemistry.

[51]  Masanori Fujita,et al.  Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. , 2003, Journal of biomedical materials research. Part A.

[52]  D. Carson,et al.  A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. Tammishetti,et al.  Synthesis, UV photo‐polymerization and degradation study of PEG containing polyester polyol acrylates , 2004 .

[54]  S. Craig,et al.  Small-molecule dynamics and mechanisms underlying the macroscopic mechanical properties of coordinatively cross-linked polymer networks. , 2005, Journal of the American Chemical Society.

[55]  A. Drake,et al.  The effect of variation of substitution on the solution conformation of heparin: a spectroscopic and molecular modelling study. , 1994, Carbohydrate research.

[56]  J. Holbrook,et al.  Low-resolution structure of the complex of human blood platelet factor 4 with heparin determined by small-angle neutron scattering. , 1986, Biochimica et biophysica acta.

[57]  D. Wirtz,et al.  Reversible hydrogels from self-assembling artificial proteins. , 1998, Science.

[58]  X. Xu,et al.  The analysis of heparin-protein interactions using evanescent wave biosensor with regioselectively desulfated heparins as the ligands. , 2001, Analytical biochemistry.

[59]  Nicholas A Peppas,et al.  Hydrogels for oral delivery of therapeutic proteins , 2004, Expert opinion on biological therapy.

[60]  A. Hoffman,et al.  Semi-interpenetrating network of poly(ethylene glycol) and poly(D, L-lactide) for the controlled delivery of protein drugs , 2005, Journal of biomaterials science. Polymer edition.

[61]  D. Spillmann,et al.  Glycosaminoglycan-protein interactions: a question of specificity , 1994 .

[62]  K. Marra,et al.  Biodegradable poly(ethylene glycol) hydrogels crosslinked with genipin for tissue engineering applications. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.

[63]  Jeffrey A. Hubbell,et al.  Functional biomaterials : Design of novel biomaterials : Biomaterials , 2001 .

[64]  J. Weiler,et al.  Pattern and spacing of basic amino acids in heparin binding sites. , 1997, Archives of biochemistry and biophysics.

[65]  D C Rees,et al.  Heparin Structure and Interactions with Basic Fibroblast Growth Factor , 1996, Science.

[66]  J. Hubbell,et al.  Systematic modulation of Michael-type reactivity of thiols through the use of charged amino acids. , 2001, Bioconjugate chemistry.

[67]  T. McCaffrey,et al.  Protection of transforming growth factor β activity by heparin and fucoidan , 1994 .

[68]  A A Poot,et al.  Binding and release of basic fibroblast growth factor from heparinized collagen matrices. , 2001, Biomaterials.